A revised excitotoxic hypothesis of schizophrenia: therapeutic implications
Embrace the positive changes and approach your health journey with confidence and optimism
Gemcitabine Galactose-modified Gemcitabine also called senescence-specific killing compound 1 (SSK1) decreases senescent cells viability in multiple cell types, in mice and human in vitro models as well as in a broad range of inductions such as irradiation, replicative exhaustion, OIS and oxidative or genotoxic stress
FOXO4-DRI enters senescent cells and competitively binds to p53 through its modified peptide sequence, displacing endogenous FOXO4 and freeing p53 to activate cell death pathways including BAX and PUMA
While these effects could be beneficial for recovery and metabolic regulation, they also introduce the potential for subtle hormonal fluctuations, which remain poorly characterized
Frequent Illness A strong immune system relies on sufficient glutathione